梯瓦制药公司 (NYSE: ...

Teva Pharmaceutical Industries raised its 2024 revenue and earnings guidance after beating third-quarter profit forecasts, ...

Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q3 2024 Earnings Call Transcript November 6, 2024 Teva Pharmaceutical ...

Teva Pharmaceutical Industries expects to work productively with the incoming Trump administration in the United States, ...

As other biopharma giants have divested their generics units to focus on the development and commercialization of innovative ...

英为财情Investing.com - 梯瓦制药 (NYSE: TEVA)星期三发布了第三季度的财报，数据显示，公司营收高于分析师的预期，每股收益超出了分析师的预期。

Teva stock plunged Wednesday — sacrificing an earlier breakout — despite beating third-quarter expectations and raising its guidance.

TEVA reports better-than-expected third-quarter results, beating both earnings and sales estimates. However, the stock declines 7%.

Analyst Jason Gerberry of Bank of America Securities reiterated a Buy rating on Teva Pharmaceutical (TEVA – Research Report), boosting ...

In terms of liquidity and interest, the mean open interest for Teva Pharmaceutical Indus options trades today is 8263.67 with ...

HOKA、UGG、Teva 等鞋履品牌母公司 Deckers Brands 财报持续传来捷报，第二季净销售额增长 20.1%，总计达到 13 亿美元。 该公司在最近三个月内的净收入为 2.423 亿美元，相较去年同期 1.785 ...

Teva Pharmaceutical Industries Limited ( (TEVA) ) has released its Q3 earnings. Here is a breakdown of the information Teva Pharmaceutical ...